Effect of individual allergen sensitization on omalizumab treatment outcomes in patients with severe allergic asthma determined using data from the Czech Anti-IgE Registry

Abstract Background Omalizumab is an efficient drug for patients with uncontrolled severe allergic asthma (SAA). However, little is known about the differences in omalizumab treatment outcomes among patients with different types of atopic sensitization. Here, we assessed the effect of sensitization...

Full description

Bibliographic Details
Main Authors: Petr Vaník, Jakub Novosad, Olga Kirchnerová, Irena Krčmová, Milan Teřl, Czech Anti-IgE Registry collaborators
Format: Article
Language:English
Published: BMC 2020-09-01
Series:Allergy, Asthma & Clinical Immunology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13223-020-00479-1